Insider Trading activities of Kv Pharmaceutical Co /de/ insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kv Pharmaceutical Co /de/ since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kv Pharmaceutical Co /de/ since year 2005. Table 2 shows the detailed insider transactions of Kv Pharmaceutical Co /de/ since 2005. The reporting company's ticker symbol is KVA / KVB. The reporting company's CIK number is 57055.
The total value of stock buying since 2005 is $7,671,238.
The total value of stock sales since 2005 is $19,322,622.
The total value of stock option exercises since 2005 is $1,748,802.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Kv Pharmaceutical Co /de/ (KVA / KVB).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-09 150,000 $6,000,000 199,000 $7,960,000 0 $0
2013-08 3,267,709 $1,671,238 0 $0 0 $0
2011-03 0 $0 100,000 $1,020,800 0 $0
2011-02 0 $0 125,000 $476,875 0 $0
2008-11 0 $0 28,000 $140,028 0 $0
2008-07 0 $0 0 $0 1,225 $35,035
2008-03 0 $0 0 $0 450 $8,716
2007-12 0 $0 0 $0 1,500 $35,550
2007-08 0 $0 0 $0 10,235 $45,463
2007-01 0 $0 0 $0 7,625 $37,285
2006-12 0 $0 0 $0 1,000 $10,108
2006-09 0 $0 50,000 $1,178,574 1,000 $10,108
2006-07 0 $0 0 $0 96,450 $1,205,914
2006-04 0 $0 0 $0 18,300 $216,718
2006-03 0 $0 0 $0 32,201 $127,396
2006-02 0 $0 104,128 $2,314,560 0 $0
2006-01 0 $0 40,000 $859,800 1,500 $16,509
2005-12 0 $0 80,000 $1,716,399 0 $0
2005-11 0 $0 15,467 $301,592 0 $0
2005-08 0 $0 188,000 $3,192,590 0 $0
2005-07 0 $0 2,850 $46,141 0 $0
2005-06 0 $0 6,750 $115,263 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Kv Pharmaceutical Co /de/ insiders (KVA / KVB)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-09-26 O'shea Robert J (10% Owner) Sale 199,000 40.00 7,960,000
2013-09-23 O'shea Robert J (10% Owner) Buy 150,000 40.00 6,000,000
2013-08-06 Robbins Lawrence M Buy 1,764,709 .46 820,589
2013-08-02 Robbins Lawrence M Buy 703,000 .55 386,650
2013-08-01 Robbins Lawrence M Buy 800,000 .58 463,999
2011-03-04 Hermelin Arnold L (10% Owner) Sale 100,000 10.21 1,020,800
2011-02-04 Parkside Financial Bank & Trust Sale 125,000 3.82 476,875
2008-11-13 Chibnall Richard H (Vice President/Finance) Sale 28,000 5.00 140,028
2008-07-18 Divis Greg J (President, Ther-Rx Corporation) Option Ex 1,225 28.60 35,035
2008-03-31 Carlie Kevin S Option Ex 450 19.37 8,716
2007-12-14 Van Vliet David A (Chief Administration Officer) Option Ex 1,500 23.70 35,550
2007-08-15 Mitchell Gerald R (Vice President and CFO) Option Ex 10,235 4.44 45,463
2007-01-02 Anderson Michael Shannon (Corp VP-Indus Presence& Dev) Option Ex 3,375 4.89 16,503
2007-01-01 Chibnall Richard H (Vice President/Finance) Option Ex 4,250 4.89 20,782
2006-12-27 Moyerman Eric D (President, Pharmaceutical Div.) Option Ex 1,000 10.11 10,108
2006-09-19 Moyerman Eric D (President, Pharmaceutical Div.) Option Ex 1,000 10.11 10,108
2006-09-15 Hermelin Marc S (Chairman & CEO) Sale 14,900 23.58 351,267
2006-09-14 Hermelin Marc S (Chairman & CEO) Sale 35,100 23.57 827,307
2006-07-26 Hermelin Marc S (Vice Chairman, CEO) Option Ex 96,450 12.50 1,205,914
2006-04-03 Hermelin David S (Vice President) Option Ex 5,250 12.10 63,525
2006-04-03 Carlie Kevin S Option Ex 13,050 11.74 153,193
2006-03-13 Moyerman Eric D (President, Pharmaceutical Div.) Option Ex 7,201 7.61 54,821
2006-03-08 Chibnall Richard H (Vice President/Finance) Option Ex 25,000 2.90 72,575
2006-02-22 Vogt Philip J (President, Ethex Corp.) Sale 5,532 22.19 122,771
2006-02-10 Johnson Alan G (Sr.. Vice Pres. & Sec.) Sale 98,596 22.23 2,191,789
2006-01-20 Chiostri Raymond F (VP; P - Particle Dyn) Option Ex 1,500 11.01 16,509
2006-01-04 Anderson Michael Shannon (CEO, Ther-RX Corpora) Sale 40,000 21.50 859,800
2005-12-14 Hermelin Marc S (Vice Chairman, CEO) Sale 80,000 21.46 1,716,399
2005-11-29 Vogt Philip J (President, Ethex Cor) Sale 12,082 19.37 234,028
2005-11-14 Vogt Philip J (President, Ethex Cor) Sale 3,385 19.96 67,564
2005-08-29 Hermelin Victor Sale 134,000 17.04 2,282,690
2005-08-15 Hermelin Victor Sale 54,000 16.85 909,900
2005-07-15 Chibnall Richard H (Vice President/Finan) Sale 2,850 16.19 46,141
2005-06-24 Schellenger Norman D Sale 3,500 16.68 58,362
2005-06-22 Schellenger Norman D Sale 3,250 17.51 56,901

Insider trading activities including stock purchases, stock sales, and option exercises of KVA / KVB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kv Pharmaceutical Co /de/ (symbol KVA / KVB, CIK number 57055) see the Securities and Exchange Commission (SEC) website.